Formoterol
- 1 lab in 1 country
- 1 trial, none about aging
- Funders: National Natural Science Foundation of China and 2 more
- Animals1
Outcomes
2SIRT1
upin mice1
1 study
SIRT1
upin mice1
Formoterol increases SIRT1 in mice.
“expression of sirtuin 1 (SIRT1) in aorta is decreased in EPO-induced AAA but remarkably elevated by medium-dose formoterol.”
Animalsin aorta of EPO-induced AAA micemedium-dose
Advanced science (Weinheim, Baden-Wurttemberg, Germany)Feb 14, 2024
Cellular senescence
downin mice1
1 study
Cellular senescence
downin mice1
Formoterol decreases cellular senescence in mice.
“senescence of vascular smooth muscle cell (VSMC) is increased by EPO while decreased by medium-dose formoterol both in vivo and in vitro”
Animalsin EPO-treated VSMCs in vivo and in vitromedium-dose
Advanced science (Weinheim, Baden-Wurttemberg, Germany)Feb 14, 2024
Associations
1Abdominal aortic aneurysm
downin mice1
1 study
Abdominal aortic aneurysm
downin mice1
Formoterol lowers the risk of abdominal aortic aneurysm in mice (10% vs 55%).
“The incidence of AAA is 0, 55%, 35%,10%, and 55% in these 5 groups, respectively.”
Animalsin ApoE-/- mice treated with EPOmedium-dose
Advanced science (Weinheim, Baden-Wurttemberg, Germany)Feb 14, 2024
Trial sponsors
Company1 trialPhase 3310 people
Latest
Advanced Science
Medium-Dose Formoterol Attenuated Abdominal Aortic Aneurysm Induced by EPO via β2AR/cAMP/SIRT1 Pathway
Experiments in miceAbdominal aortic aneurysm